A phase I study of vorinostat (suberoylanilide hydroxamic acid, SAHA) in combination with 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) in patients with advanced colorectal cancer (CRC)
Fakih, M. G., Pendyala, L., Toth, K., Creaven, P., Soehnlein, N., Litwin, A., Trump, D.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solid tumors
FAKIH, Marwan G, PENDYALA, Lakshmi, SMITH, Patrick F, CREAVEN, Patrick J, REID, Mary E, BADMAEV, Vladimir, AZRAK, Rami G, PREY, Joshua D, LAWRENCE, David, RUSTUM, Youcef M
Published in Clinical cancer research (15.02.2006)
Published in Clinical cancer research (15.02.2006)
Get full text
Journal Article
Lack of Microvessels in Well-Differentiated Regions of Human Head and Neck Squamous Cell Carcinoma A253 Associated with Functional Magnetic Resonance Imaging Detectable Hypoxia, Limited Drug Delivery, and Resistance to Irinotecan Therapy
BHATTACHARYA, Arup, TOTH, Karoly, MAZURCHUK, Richard, SPERNYAK, Joseph A, SLOCUM, Harry K, PENDYALA, Lakshmi, AZRAK, Rami, SHOUSONG CAO, DURRANI, Farukh A, RUSTUM, Youcef M
Published in Clinical cancer research (01.12.2004)
Published in Clinical cancer research (01.12.2004)
Get full text
Journal Article
Uptake and metabolism of iproplatin in murine L1210 cells
Pendyala, L, Walsh, J R, Huq, M M, Arakali, A V, Cowens, J W, Creaven, P J
Published in Cancer chemotherapy and pharmacology (1989)
Published in Cancer chemotherapy and pharmacology (1989)
Get more information
Journal Article
A phase I study of vorinostat (suberoylanilide hydroxamic acid) in combination with 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) in patients with advanced colorectal cancer (CRC)
Fakih, M. G., Pendyala, L., Smith, P., Creaven, P., Toth, K., Zwiebel, J., Frankel, S., Litwin, A., Huffman, L., Egorin, M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Phase I, pharmacokinetic (PK), pharmacodynamic study of paricalcitol [19-nor-1 alpha, 25-(OH)2 D2] in combination with gemcitabine [2’,2’ difluorodeoxycytidine] in patients with advanced malignancies
Trump, D., Javle, M., Muindi, J., Pendyala, L., Yu, W., Ramnath, N., Ross, M., Fakih, M., Iyer, R., Johnson, C.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells
Minderman, Hans, Conroy, Jeffrey M, O'Loughlin, Kieran L, McQuaid, Devin, Quinn, Paul, Li, Song, Pendyala, Lakshmi, Nowak, Norma J, Baer, Maria R
Published in Molecular cancer therapeutics (01.06.2005)
Published in Molecular cancer therapeutics (01.06.2005)
Get full text
Journal Article
Clinical development of iproplatin (CHIP)
Creaven, P J, Pendyala, L, Madajewicz, S
Published in Drugs under experimental and clinical research (1986)
Get more information
Published in Drugs under experimental and clinical research (1986)
Journal Article
Celecoxib in combination with irinotecan (CPT-11), 5-fluorouracil and leucovorin in patients with advanced cancer: A phase I, pharmacokinetic study
Creaven, P. J., Javle, M. M., Pendyala, L., Smith, P., Noel, D. C., Iyer, R. V., Lawrence, D. D., Rustum, Y. M.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
A phase I and biological correlates study of capecitabine (CAP) + oxaliplatin (OX) + radiation therapy (RT) in locally advanced rectal cancer (LARC)
Fakih, M. G., Rajput, A., Yang, G. Y., Pendyala, L., Toth, K., Lawrence, D. D., Smith, J. L., Soehnlein, N. A., Flaherty, L., Rustum, Y. M.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
A phase I and pharmacokinetic (PK) study of high dose selenomethionine (SLM) in combination with irinotecan (IRI) in patients with advanced solid tumors
Rustum, Y., Pendyala, L., Creaven, P. J., Smith, P., Azrak, R., Cao, S., Durrani, F., Lawrence, D. D., Badmaev, V., Diane, N. C., Fakih, M. G.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article